WST11 (padeliporfin)

padeliporfin · Steba Biotech S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WST11 (padeliporfin), covering 2016-04-18 to 2016-04-18. Get the full timeline:

Most recent: Clinical Trial Update: Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma [Phase 2]